# To Study the Safety and Efficacy of Simvastatin in Patients With Hepatopulmonary Syndrome in Cirrhosis.

> **NCT05187715** · NA · UNKNOWN · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 45 (estimated)

## Conditions studied

- Liver Cirrhosis

## Interventions

- **DRUG:** Simvastatin 40mg
- **OTHER:** Placebo
- **OTHER:** Standard medical Treatment

## Key facts

- **NCT ID:** NCT05187715
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-26
- **Primary completion:** 2023-10
- **Final completion:** 2023-10
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2022-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05187715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05187715, "To Study the Safety and Efficacy of Simvastatin in Patients With Hepatopulmonary Syndrome in Cirrhosis.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05187715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*